Evaluation of Nutritional Status and Anxiety Levels in Patients Applying to the Radiation Oncology Outpatient Clinic during the COVID-19 Pandemic: Turkish Society for Radiation Oncology Group Study (TROD 12:02)
Tarih
2022Yazar
Caloglu, Vuslat Yurut
Akmansu, Muge
Yalman, Deniz
Gul, Sule Karabulut
Kocak, Zafer
Alicikus, Zumre Arican
Serarslan, Alparslan
Akyurek, Serap
Mustafayev, Teuta Zoto
Demiroz, Candan
Oksuz, Didem Colpan
Kanyilmaz, Gul
Altinok, Pelin
Saglam, Esra Kaytan
Balkanay, Ayben Yentek
Akboru, Halil
Keven, Emine
Yildirim, Berna
Onal, Cem
Igdem, Sefik
Ozkan, Emre
Ozdener, Fatih
Caloglu, Murat
Üst veri
Tüm öğe kaydını gösterÖzet
Cancer patients often face malnutrition, which negatively affects their response to cancer treatment. This study aims to analyze the effects of the COVID-19 pandemic on nutritional status and anxiety in cancer patients with different types and stages of cancer. This is a cross-sectional cohort study that includes 1,252 patients with varying cancer types from 17 radiation oncology centers. The nutritional risk scores (NRS-2002) and coronavirus anxiety scale (CAS) scores of all patients were measured. NRS-2002 >= 3 and CAS >= 5 were accepted as values at risk. Of all patients, 15.3% had NRS-2002 >= 3. Breast cancer was the most prevalent cancer type (24.5%) with the lowest risk of nutrition (4.9%, p < 0.001). Nutritional risk was significantly higher in patients with gastrointestinal cancer, head and neck cancer, and lung cancer (p < 0.005) and in patients with stage IV disease (p < 0.001). High anxiety levels (CAS >= 5) were significantly related to voluntary avoidance and clinical postponement of hospital visits due to the pandemic (p < 0.001), while clinical postponement was particularly frequent among patients with NRS-2002 < 3 (p = 0.0021). Fear and anxiety in cancer patients with COVID-19 cause hesitations in visiting hospitals, leading to disrupted primary and nutritional treatments. Thus, nutritional monitoring and treatment monitoring of cancer patients are crucial during and after radiotherapy.